May 25th, 2022 (Earnings Report) Dear Reader,
HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings starting today, May 25th. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
CureVac
Symbol: CVAC
Recent Price: $$18.45
Average Analyst Price Target: $44.50 (141.19%)
Last Year's EPS: -$0.62
Consensus EPS Forecast: ―
Expected Earnings Date: May 24 2022
Recent Analyst Action: Zhiqiang Shu, analyst at Berenberg Bank, reiterates coverage on CureVac (CVAC) in the Healthcare sector with a Buy rating and a price target of $ 52 (3 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Fisher & Paykel Healthcare Corporation Limited
Symbol: FSPKF
Recent Price: $$13.13
Average Analyst Price Target: $25.16 (91.62%)
Last Year's EPS: $0.27
Consensus EPS Forecast: ―
Expected Earnings Date: Nov 21 2022
Recent Analyst Action: John Deakin-Bell, analyst at Citigroup, reiterates coverage on Fisher & Paykel Healthcare Corporation Limited (FSPKF) in the Healthcare sector with a Buy rating and a price target of n/a (12 hours ago).
Click for complete article >>--------------------------------------------------------------------------
Quoin Pharmaceuticals
Symbol: QNRX
Recent Price: $$0.64
Average Analyst Price Target: $5.00 (681.37%)
Last Year's EPS: ―
Consensus EPS Forecast: ―
Expected Earnings Date: May 24 2022
Recent Analyst Action: Aydin Huseynov, analyst at Ladenburg Thalmann & Co., reiterates coverage on Quoin Pharmaceuticals (QNRX) in the Healthcare sector with a Buy rating and a price target of $ 2 (2 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Ayr Wellness
Symbol: AYRWF
Recent Price: $$6.39
Average Analyst Price Target: $30.07 (370.58%)
Last Year's EPS: -$0.36
Consensus EPS Forecast: -$0.27
Expected Earnings Date: May 25 2022
Recent Analyst Action: Andrew Semple, analyst at Echelon Wealth Partners, reiterates coverage on Ayr Wellness (AYRWF) in the Healthcare sector with a Buy rating and a price target of $ 54.7 (1 month ago).
Click for complete article >>--------------------------------------------------------------------------
Collplant Holdings
Symbol: CLGN
Recent Price: $$9.01
Average Analyst Price Target: $17.00 (88.68%)
Last Year's EPS: $0.88
Consensus EPS Forecast: -$0.14
Expected Earnings Date: May 25 2022
Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on Collplant Holdings (CLGN) in the Healthcare sector with a Buy rating and a price target of $ 17 (2 months ago).
Click for complete article >>--------------------------------------------------------------------------
Mednax
Symbol: MD
Recent Price: $$18.27
Average Analyst Price Target: $22.29 (22.00%)
Last Year's EPS: $0.41
Consensus EPS Forecast: $0.48
Expected Earnings Date: Aug 03 2022
Recent Analyst Action: Whit Mayo, analyst at SVB Securities, reiterates coverage on Mednax (MD) in the Healthcare sector with a Hold rating and a price target of $ 20 (2 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Patterson Companies
Symbol: PDCO
Recent Price: $$31.25
Average Analyst Price Target: $37.00 (18.40%)
Last Year's EPS: $0.38
Consensus EPS Forecast: $0.56
Expected Earnings Date: May 25 2022
Recent Analyst Action: A.J. Rice, analyst at Credit Suisse, reiterates coverage on Patterson Companies (PDCO) in the Healthcare sector with a Buy rating and a price target of $ 36 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Taro Pharmaceutical
Symbol: TARO
Recent Price: $$35.83
Average Analyst Price Target: $73.00 (103.74%)
Last Year's EPS: -$0.78
Consensus EPS Forecast: $0.88
Expected Earnings Date: May 25 2022
Recent Analyst Action: Ram Selvaraju, analyst at H.C. Wainwright, reiterates coverage on Taro Pharmaceutical (TARO) in the Healthcare sector with a Buy rating and a price target of $ 73 (2 months ago).
Click for complete article >>--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com